Código QR (código de barras bidimensional)

Impact of inotuzumab ozogamicin as bridging therapy and tumor burden in CAR-T therapy for B-acute lymphoblastic leukemia

IntroductionInotuzumab ozogamicin is increasingly being used as bridging therapy (BT) prior to chimeric antigen receptor T-cell (CAR-T) in relapsed/refractory B-cell acute lymphoblastic leukemia (R/R ALL), but its impact on CAR-T expansion and clinical outcomes remains controversial.MethodsThis stud...

Fuld beskrivelse

Na minha lista:
Principais autores: Patricia Alcalde-Mellado, Victoria Ruiz-Maldonado, Javier Delgado-Serrano, Luzalba Sanoja-Flores, Marta Reinoso-Segura, Laura Pérez-Ortega, Belén Sierro-Martínez, Estefanía García-Guerrero, Concepción Pérez de Soto, José María Pérez-Hurtado, José González-Campos, José Antonio Pérez-Simón, Águeda Molinos-Quintana, Teresa Caballero-Velázquez
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2025-12-01
Serier:Frontiers in Immunology
Fag:
acute lymphoblastic leukemia
bridging therapy
CAR-T
flow cytometry
inotuzumab ozogamicin
stem memory T cells
Online adgang:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1725878/full
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker